Get the Daily Brief
Latest Biotech News
FDA Gives Full Nod to Precigen’s Rare Disease Gene Therapy
The US FDA has remarkably granted full and accelerated approval to Precigen’s gene therapy Papzimeos for treating recurrent respiratory papillomatosis (RRP), a rare disease characterized by benign...
Pfizer’s Sickle Cell Drug Fails Phase 3 Trial
Pfizer announced the failure of its sickle cell disease candidate inclacumab in a Phase 3 clinical trial, where the drug did not demonstrate a statistically significant benefit over placebo. This...
Human Embryo Implantation Captured in 3D Real Time
Researchers at the Institute for Bioengineering of Catalonia, collaborating with Dexeus University Hospital, have for the first time visualized and recorded human embryo implantation in real time...
Breakthrough Cancer Drug Shows Promise in Clinical Trial
A recent clinical trial has highlighted a novel cancer drug with efficacy in eradicating aggressive tumors. The investigation focused on a CD40 agonist antibody, a class historically limited by...
Advances in Nanobody Therapy Target Lung Cancer
Scientists at the Korea Research Institute of Bioscience and Biotechnology have developed a cutting-edge nanobody-based therapeutic modality specifically targeting lung cancer cells. The approach...
New Insights into Immune Cell Interactions Shape Immunotherapy
Groundbreaking research reveals a complex interplay between regulatory T cells (Tregs) and pro-inflammatory Th17 cells mediated by a balance of cytokines including TGF-β, IL-6, and IL-2. This...
HHS Revives Childhood Vaccine Safety Task Force Amid Controversy
In a significant policy move, the US Department of Health and Human Services reinstated the Task Force on Safer Childhood Vaccines, disbanded since 1998. This action follows a lawsuit filed by the...
Kickstarting RNA Analysis: CUT&Tag Buffer Modification Unlocks New Capabilities
German researchers from the University of Cologne have optimized the CUT&Tag assay by reducing salt concentrations in buffers, overcoming prior limitations preventing measurement of transcription...
Major Investment Backs Gene Therapy Startup Kriya Therapeutics
Kriya Therapeutics, a biotech company focused on gene therapy, has secured a $313 million funding round, marking a significant financial boost for its development programs. Operating between North...
Biopharma Deal Volume Slows Despite Surge in Deal Value
The biopharmaceutical industry experienced a record-high surge in deal values totaling $164 billion in the first seven months of 2025, a 36% increase year-over-year. However, the total number of...
FDA Accelerates Rare Disease Gene Therapy Approval
The U.S. Food and Drug Administration has granted a rapid, full approval to Precigen Inc.'s gene therapy Papzimeos for recurrent respiratory papillomatosis (RRP), a rare disease causing benign...
Pfizer’s Sickle Cell Drug Stumbles in Late-Stage Trial
Pfizer's sickle cell therapy candidate inclacumab failed to demonstrate efficacy in a pivotal Phase 3 trial, according to recent announcements. This failure follows Pfizer's voluntary withdrawal...
Human Embryo Implantation Captured in 3D and Real Time
Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital have achieved the first real-time, three-dimensional recording of human embryo implantation on synthetic...
Innovations in Cancer Immunotherapy and Biomarkers
Emerging studies are advancing precision oncology and immunotherapy through novel biomarker discoveries and drug development. A Fudan University-led study introduced a blood test predicting...
Advances in Neonatal and Pediatric Therapies
Breakthrough clinical developments are emerging in neonatal and pediatric care. Airway Therapeutics announced an expanded multinational Phase III trial of zelpultide alfa, targeting...
Breakthroughs in Genetic and Epigenetic Research
Recent research breakthroughs deepen understanding of gene regulation and chromatin dynamics impacting various diseases. German scientists developed a buffer modification enabling CUT&Tag assays...
Biopharma Funding and Market Trends in 2025
The biopharma sector saw record-breaking deal values in the first seven months of 2025, totaling $164 billion in non-M&A deals, a 36% increase over 2024. However, 2025 witnessed a notable IPO...
Environmental and Structural Biotechnologies Progress
Innovative biotechnologies addressing environmental and structural challenges have advanced significantly. Studies reveal the seismic vulnerability of unreinforced masonry facades improved by...
Neuroscience and Mental Health Insights
Recent studies provide new perspectives on mental health and neurological disorders. Research links loneliness with depression in adolescent and young adult cancer survivors, highlighting...
Big Data, AI, and Computational Biology Transformations
Cutting-edge developments are reshaping biotech through AI and computational advances. Large language models are revolutionizing drug discovery, enhancing speed and accuracy in molecular design....